Form 4 Tracker
Keenova Therapeutics plc
NONE

44 insider filings · Latest: Jul 21, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 20, 2026May 22 12:59 AMSilver Point Capital L.P.10% Owner
Purchase
210,000$90.50$19.0M6,035,214(D)

View →

May 19, 2026May 22 12:59 AMSilver Point Capital L.P.10% Owner
Purchase
187,500$90.50$17.0M5,825,214(D)

View →

Apr 17, 2026Apr 17 9:23 PMSilver Point Capital L.P.10% Owner
Purchase
410,000$90.50$37.1M5,637,714(D)

View →

Apr 15, 2026Apr 17 9:23 PMSilver Point Capital L.P.10% Owner
Purchase
275,000$88.50$24.3M5,227,714(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 23, 2026Feb 26 1:50 AMPaul EfronDirector
Grant/Award
3,98410,494(D)

View →

Feb 23, 2026Feb 26 1:48 AMKatina DortonDirector
Grant/Award
3,98431,882(D)

View →

Feb 23, 2026Feb 26 1:47 AMLeslie E DonatoDirector
Grant/Award
3,9848,866(D)

View →

Feb 23, 2026Feb 26 1:45 AMPaul BisaroDirector
Grant/Award
3,98447,225(D)

View →

← Previous

Page 3 of 3